DK0752884T3 - Fremgangsmåde til behandling af auto-immune sygdomme ved anvendelse af type 1 interferoner - Google Patents

Fremgangsmåde til behandling af auto-immune sygdomme ved anvendelse af type 1 interferoner

Info

Publication number
DK0752884T3
DK0752884T3 DK95916293T DK95916293T DK0752884T3 DK 0752884 T3 DK0752884 T3 DK 0752884T3 DK 95916293 T DK95916293 T DK 95916293T DK 95916293 T DK95916293 T DK 95916293T DK 0752884 T3 DK0752884 T3 DK 0752884T3
Authority
DK
Denmark
Prior art keywords
type
interferons
treatment
autoimmune diseases
animal
Prior art date
Application number
DK95916293T
Other languages
Danish (da)
English (en)
Inventor
Staley Armstrong Brod
Original Assignee
Res Dev Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26920717&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0752884(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Res Dev Foundation filed Critical Res Dev Foundation
Application granted granted Critical
Publication of DK0752884T3 publication Critical patent/DK0752884T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK95916293T 1994-04-12 1995-04-11 Fremgangsmåde til behandling af auto-immune sygdomme ved anvendelse af type 1 interferoner DK0752884T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22663194A 1994-04-12 1994-04-12
US40827195A 1995-03-24 1995-03-24
PCT/US1995/004420 WO1995027502A1 (en) 1994-04-12 1995-04-11 Method of treating auto-immune diseases using type one interferons

Publications (1)

Publication Number Publication Date
DK0752884T3 true DK0752884T3 (da) 2004-11-22

Family

ID=26920717

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95916293T DK0752884T3 (da) 1994-04-12 1995-04-11 Fremgangsmåde til behandling af auto-immune sygdomme ved anvendelse af type 1 interferoner

Country Status (13)

Country Link
EP (1) EP0752884B1 (ar)
JP (1) JPH09511989A (ar)
KR (1) KR100424212B1 (ar)
AT (1) ATE271879T1 (ar)
AU (1) AU695260B2 (ar)
CA (1) CA2187550A1 (ar)
DE (1) DE69533311T2 (ar)
DK (1) DK0752884T3 (ar)
ES (1) ES2224124T3 (ar)
IL (1) IL113280A (ar)
NZ (1) NZ284276A (ar)
SA (1) SA95160081B1 (ar)
WO (1) WO1995027502A1 (ar)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5906816A (en) * 1995-03-16 1999-05-25 University Of Florida Method for treatment of autoimmune diseases
US6372206B1 (en) 1989-03-02 2002-04-16 University Of Florida Orally-administered interferon-TAU compositions and methods
AU724689B2 (en) 1996-05-09 2000-09-28 Pharma Pacific Pty Ltd Method of treatment
AUPN976596A0 (en) * 1996-05-09 1996-05-30 Pharma Pacific Pty Ltd Stimulation of host defence mechanisms
US7144574B2 (en) 1999-08-27 2006-12-05 Maxygen Aps Interferon β variants and conjugates
US7431921B2 (en) 2000-04-14 2008-10-07 Maxygen Aps Interferon beta-like molecules
US6531122B1 (en) 1999-08-27 2003-03-11 Maxygen Aps Interferon-β variants and conjugates
CZ2002521A3 (cs) * 1999-08-27 2002-05-15 Maxygen Aps Nové molekuly podobné interferonu beta
UA86749C2 (en) * 2002-09-27 2009-05-25 Байоджен Айдек Ма Инк. THERAPIES FOR CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY USING INTERFERON-в
CA2511209A1 (en) * 2002-12-26 2004-07-15 Daiichi Suntory Pharma Co., Ltd. Agent for treatment of pemphigoid
US20210228687A1 (en) * 2018-06-01 2021-07-29 Ilc Therapeutics Ltd Compositions and methods relating to the treatment of diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA878295B (en) * 1986-11-06 1988-05-03 Amarillo Cell Culture Co. Inc. Treatment of immuno-resistant disease

Also Published As

Publication number Publication date
KR100424212B1 (ko) 2004-07-21
EP0752884B1 (en) 2004-07-28
WO1995027502A1 (en) 1995-10-19
JPH09511989A (ja) 1997-12-02
KR970702063A (ko) 1997-05-13
IL113280A0 (en) 1995-07-31
IL113280A (en) 2004-12-15
ATE271879T1 (de) 2004-08-15
EP0752884A4 (en) 1999-04-07
CA2187550A1 (en) 1995-10-19
EP0752884A1 (en) 1997-01-15
NZ284276A (en) 2000-07-28
AU2283995A (en) 1995-10-30
DE69533311D1 (de) 2004-09-02
AU695260B2 (en) 1998-08-13
ES2224124T3 (es) 2005-03-01
SA95160081B1 (ar) 2005-09-19
DE69533311T2 (de) 2005-07-21

Similar Documents

Publication Publication Date Title
BR9709068A (pt) Processo de tratamento.
DK0880350T3 (da) Behandling af dissemineret sklerose
DK1003546T3 (da) Fremgangsmåde til behandling af patienter ramt af dissemineret sklerose ved anvendelse af konsensus interferon
DE69033487D1 (de) Behandlung von autoimmunkrankheiten durch verabreichung von autoantigenen in form von aerosol
EA199800674A1 (ru) Способ повторного лечения больных гепатитом с
DE69133516D1 (de) Behandlung von autoimmunkrankheiten durch orale verabreichung von autoantigenen
DK0752884T3 (da) Fremgangsmåde til behandling af auto-immune sygdomme ved anvendelse af type 1 interferoner
EA200601059A1 (ru) Сложные моноэфиры пробукола для лечения сердечно-сосудистых и воспалительных заболеваний
FI943625A (fi) Menetelmiä tulehduksellisten ihotautien hoitamiseksi
BR9809678A (pt) Derivados de triptolìdeo úteis no tratamento de doenças autoimunes
ATE249835T1 (de) Immunoregulator
NO964199L (no) Behandling av autoimmun sykdom ved anvendelse av oral tolerisering og/eller type I interferon
NO964200L (no) Behandling av autoimmun sykdom ved anvendelse av oral tolerisering og/eller Th2-forsterkende cytokiner
CO4940456A1 (es) Metodo antiinflamatorio
DE69622472D1 (de) Behandlung von Krankheiten durch Induktion von BEF-1 Transkriptionsfaktor
NO881629L (no) Anvendelse av antigene stoffer ved behandling av lidelseri mage-tarm-kanalen.
PT1237562E (pt) Processo de preparacao de extractos de micania contendo micanolida e di-hidromicanolida e utilizacao no tratamento das doencas proliferativas
FR2559668B1 (fr) Compositions pharmaceutiques pour le traitement du diabete et de maladies et defauts de fonctionnement du foie
BR9809673A (pt) Derivados de triptolida úteis no tratamento de doenças autoimunes
LV10191A (lv) Farmaceitiski lidzekli hepatita B virusa izraisito infekciju un slimibu arstesanai
PT1150703E (pt) Terapia de esclerose multipla com chaperonina 10 e beta-interferao
ZA952797B (en) Method of treating auto-immune diseases using type one interferons
DE69729201T2 (de) Sulfonfluoride zur behandlung von der alzheimerischen krankheit
DK0859630T3 (da) Kombination af termozolomid og alfa-IFN til behandling af fremskreden cancer
EA200300222A1 (ru) Лечение гепатита c с помощью тимозина, интерферона и рибавирина